Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SETD7 | Q8WTS6 | 1/20 | 0.53 |
| ▸ | FNTA | P49354 | 1/20 | 0.48 |
| ▸ | FNTB | P49356 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 7/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.41 |
| ▸ | PTAFR | P25105 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | HTR2B | P41595 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | HTR3A | P46098 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12752301 | 0.90 | SETD7 (0.50) | SETD7FNTAFNTBRAB9ASMN1; SMN2 | |
| SCHEMBL1472918 | 0.84 | GPR119 (0.48) | SETD7FNTAFNTB | |
| SCHEMBL14252952 | 0.80 | SETD7 (0.51) | SETD7FNTAFNTBRAB9ASMN1; SMN2 | |
| SCHEMBL22773372 | 0.79 | OPRD1 (0.49) | SETD7FNTAFNTBRAB9ASMN1; SMN2 | |
| SCHEMBL22491496 | 0.75 | FNTA (0.47) | SETD7FNTAFNTBOPRD1OPRK1 | |
| SCHEMBL22773331 | 0.74 | SETD7 (0.50) | SETD7FNTAFNTBOPRD1OPRK1 | |
| SCHEMBL22491409 | 0.74 | SETD7 (0.50) | SETD7FNTAFNTBOPRD1OPRK1 | |
| SCHEMBL17714090 | 0.73 | PROKR1 (0.48) | RAB9ASMN1; SMN2 | |
| SCHEMBL5702311 | 0.73 | ALDH1A1 (0.52) | RAB9ASMN1; SMN2LMNAHPGDHDAC3 | |
| SCHEMBL12752306 | 0.72 | FNTA (0.47) | FNTAFNTBSMN1; SMN2OPRD1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3717477-B1 | NEW HETEROCYCLIC COMPOUNDS | HOFFMANN LA ROCHE (CH) | 2022-07-20 | — | — | EP | disclosed |
| US-20200392125-A1 | HETEROCYCLIC COMPOUNDS | HOFFMANN-LA ROCHE INC. (US) | 2020-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200392125-A1 | HETEROCYCLIC COMPOUNDS | LPXN, MLX, CCNY | SETD7 1281/4885FNTA 2173/4885FNTB 1487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.